FilingSEC EDGAR8-K
Kyntra Bio Reduces Royalty Financing Obligations by $60 Million
· SEC accepted
StageAgreement Amended
Filing content
Kyntra Bio amended its royalty financing agreement, reducing the maximum payment obligation from $125 million to $65 million after an accelerated $42.6 million payment.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…